Factor V variants, activated protein C resistance and venous thromboembolism

被引：2
|
作者：
Simioni, P
Kalafatis, M
Manfrin, D
Tormene, D
Girolami, A
机构：
[1] Univ Padua, Inst Med Semeiot, I-35100 Padua, Italy
[2] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA
来源：
BLOOD COAGULATION & FIBRINOLYSIS | 1998年 / 9卷 / 07期
关键词：
D O I：
10.1097/00001721-199810000-00015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：661 / 662
页数：2
相关论文
共 50 条
  • [21] Low level of circulating activated protein C is a risk factor for venous thromboembolism
    España, F
    Vayá, A
    Mira, Y
    Medina, P
    Estellés, A
    Villa, P
    Falcó, C
    Aznar, J
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1368 - 1373
  • [22] Prevalence of activated protein C resistance due to Factor V Leiden mutation among south Asians (India and Pakistan) with venous thromboembolism.
    Perumandla, S
    Patsiornik, Y
    Mahajan, N
    Ohri, A
    BLOOD, 2004, 104 (11) : 97B - 97B
  • [23] Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation
    De Mitrio, V
    Marino, R
    Scaraggi, FA
    Di Bari, L
    Giannoccaro, F
    Petronelli, M
    Ranieri, P
    Tannoia, N
    Schiraldi, O
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (07) : 409 - 416
  • [24] Tamoxifen-associated venous thrombosis and activated protein C resistance due to Factor V Leiden
    Weitz, IC
    Israel, VK
    Liebman, HA
    CANCER, 1997, 79 (10) : 2024 - 2027
  • [25] Is the resistance to activated protein C always associated with factor V Leiden mutation in deep venous thrombosis?
    Hizem, S.
    Magdoud, K.
    Mahjoub, T.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2008, 23 (06): : 389 - 393
  • [26] Resistance to activated protein C (APCR) in infants and children with venous or arterial thromboembolism.
    Gottl, UN
    Koch, HG
    Kohlhase, B
    Ashka, I
    Kehrel, B
    Schneppenheim, R
    BLOOD, 1995, 86 (10) : 793 - 793
  • [27] Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism
    Haim, N
    Lanir, N
    Hoffman, R
    Haim, A
    Tsalik, M
    Brenner, B
    AMERICAN JOURNAL OF MEDICINE, 2001, 110 (02): : 91 - 96
  • [28] Acquired activated protein C resistance is common in cancer patients with venous thromboembolism.
    Hoffman, R
    Haim, N
    Lanir, N
    Haim, A
    Tsalik, M
    Brenner, B
    BLOOD, 1999, 94 (10) : 649A - 649A
  • [29] Activated protein C resistance and factor V Leiden - A review
    Rosendorff, Adam
    Dorfman, David M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (06) : 866 - 871
  • [30] Activated protein C resistance testing for factor V Leiden
    Kadauke, Stephan
    Khor, Bernard
    Van Cott, Elizabeth M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (12) : 1147 - 1150
12345